Biohaven (BHVN) Operating Leases (2021 - 2026)

Biohaven has reported Operating Leases for 6 years, with the latest figure at $38.4 million in Q1 2026.

• Quarterly Operating Leases rose 24.54% year-over-year to $38.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.4 million (up 24.54% YoY) and the FY2025 annual result came in at $40.0 million, up 9.22% from the prior year.
• Operating Leases fell to $38.4 million in Q1 2026 per BHVN's latest filing, from $40.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $40.4 million in Q3 2025 and troughed at $25.3 million in Q3 2024.
• A 5-year average of $31.4 million and a median of $29.8 million in 2023 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2022 and 2024: Operating Leases soared 993.35% in 2022, then retreated 10.51% in 2024.
• Over 5 years, Operating Leases stood at $30.6 million in 2022, then slipped by 9.85% to $27.6 million in 2023, then jumped by 32.7% to $36.6 million in 2024, then advanced by 9.22% to $40.0 million in 2025, then declined by 3.99% to $38.4 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $38.4 million, $40.0 million, and $40.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.